ADH-1: Phase I/IIb data

Data from 16 evaluable patients in an ongoing, U.S. Phase I/llb trial (AHX-01-007) showed 8 complete responses at 3 months, following treatment with ADH-1 plus isolated limb infusion of melphalan. Add...